Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Leukemia, Myeloid, Acute 7Myelodysplastic Syndromes 5Brain Neoplasms 4Lymphoma 3Leukemia 3Glioblastoma 3Sarcoma 2Ovarian Neoplasms 2Lymphoma, Large B-Cell, Diffuse 2Leukemia, Lymphocytic, Chronic, B-Cell 2Glioma 2Astrocytoma 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Thyroid Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Spinal Cord Neoplasms 1Solid Tumors 1Small Cell Lung Carcinoma 1Sarcoma, Kaposi 1Refractory Solid Tumors 1Oropharyngeal Neoplasms 1Optic Nerve Glioma 1Neurologic Manifestations 1Neuroectodermal Tumors 1Neoplasms, Neuroepithelial 1Neoplasms 1Mouth Neoplasms 1Mesothelioma, Malignant 1Mesothelioma 1

Interventions

Surveys and Questionnaires 3pazopanib 2Oxaliplatin 2Erlotinib Hydrochloride 2Cetuximab 2Bevacizumab 2satraplatin 1ixazomib 1Vorinostat 1Videotape Recording 1Valproic Acid 1Trastuzumab 1Platinum 1Leucovorin 1Lapatinib 1LY 2275796 1Fluorouracil 1Everolimus 1Capecitabine 1Azacitidine 1Albumin-Bound Paclitaxel 110-propargyl-10-deazaaminopterin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Advanced Cancers × Valproic Acid × Clear all
NCT00496444 2012-08-01

Azacytidine and Valproic Acid in Patients With Advanced Cancers

M.D. Anderson Cancer Center

Phase 1 Completed
69 enrolled

Advanced Cancers

Data powered by HemOnc (CC BY 4.0) Colophon âš¡